6.45BCAD
Type
Common Stock
Exchange
NEO
Currency Code
CAD
Currency Name
Canadian Dollar
Country Name
Canada
Country ISO
CA
ISIN
-
CUSIP
-
Sector
Healthcare
Industry
Drug Manufacturers - General
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
0.26
PEG Ratio
0.01
Book Value
41.23
Dividend Share
6.23
Dividend Yield
60.14%
Earnings Share
38.46
Wall Street Target Price
-
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
72,248,999,936
Gross Profit TTM
59,845,001,216
EBITDA
36,215,001,088
Profit Margin
34.99%
Return On Assets TTM
20.74%
Return On Equity TTM
107.46%
Revenue Per Share TTM
2.6602
Qtly Revenue Growth YOY
55.50%
Diluted Eps TTM
38.46
Qtly Earnings Growth YOY
169.90%
Trailing PE
0.26
Forward PE
0
Price Sales TTM
0.1249
Price Book MRQ
0.2165
Enterprise Value Revenue
12
Enterprise Value EBITDA
25
29.11
3.71%30.86
0.65%11.72
0.09%25.64
0.00%40.78
-2.23%26.63
-1.63%26.63
-1.63%26.39
-0.71%25.42
-0.66%26.45
-0.49%